Genaera Corp Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genaera Corp

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tom pope	5/3/2005 1:16:26 PM
	Read Replies (1) of 96

And so the stock craters after digesting this news: Genaera announces interim Evizon Phase II AMD data 2005-05-03 11:58:58 2.20 +0.10: Co announces positive interim clinical trial results, including safety data and visual acuity outcomes, from a multi-center, randomized, masked, U.S. Phase II clinical trial (MSI-1256F-208)(Trial 208). The study is one of a continuing series evaluating Evizon (squalamine lactate) for the treatment of choroidal neovascularization associated with age-related macular degeneration. Evizon with concomitant PDT was well tolerated in all subjects, with no drug-related serious adverse events reported to date by subjects involved in the study.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next